About us

Medex was founded in June 2004 as a business project initiated by three physicians—specialists in pharmaceutical marketing—and a private investor. In October the company obtained its license for wholesale trade in medicinal products and began commercial operations in December 2004, focusing on participation in centralized tenders for the supply of medicinal products to the Ministry of Health, as well as in procurement procedures of healthcare institutions across the country.

The company’s efforts are directed toward expanding its portfolio by offering and distributing high-quality products from leading manufacturers that do not compete directly with one another. Our client base includes all major and financially stable hospitals in the country, as well as the Ministry of Health as a central purchaser of certain pharmaceutical products.

Currently, the company employs more than 60 professionals. The sales and promotional teams consist of highly qualified specialists—physicians and pharmacists—with extensive experience in pharmaceutical marketing. The company has established a reputation as a loyal partner and a true driving force behind the market presence of the products it represents.

Expertise

The company’s expertise is primarily focused on tender activities, logistics, and the distribution of medicinal products. The high requirements set by the authorities regulating tender procedures, as well as by healthcare institutions, necessitate a substantial level of competence regarding the pharmaceutical market and the competitive environment. The successful development of the company serves as evidence of the professionalism of our management and the dedication of our highly committed specialists.

Competencies

The company’s core competencies are primarily related to public procurement procedures — both hospital and state. The company owes its leading position to its strong customer-service orientation and its substantial efforts in key account management.

Еffectiveness

The Company’s effectiveness stems from its flat organizational structure and professional team, driven by motivation, focus, and flexibility in all operations. Medex is currently the third-largest company by market share in the hospital segment in Bulgaria, according to IQVIA.

Partnerships

At the national level, Medex is a key supplier for all relevant hospitals of oncology therapies from Astellas, Amgen, Pierre Fabre, Merck, Bayer, Mylan, Pfizer, Sandoz, Servier, Takeda, Teva, and others; coagulation factors (Takeda); hemodialysis therapies (Sandoz, EwoPharma, Alkaloid); as well as critical-care products (infusion solutions, low-molecular-weight heparins and heparin, anesthetics, parenteral nutrition, and anti-infective agents) for the hospital market.

Medex’s organizational structure ensures complete territorial coverage across the country. The company supports the entire process—from preparing tender specifications to the active promotion of awarded products.

Medex is a marketing partner and specialized distributor for the hospital portfolios of the following companies with established local affiliates in Bulgaria:

Sandoz, Pierre Fabre, Baxter, Takeda, Alkaloid.

Medex Ltd. is the main distributor of the hospital portfolio of the following companies:

Astellas, Amgen, Takeda, Merck, Mylan, Polpharma, Pfizer, Teva, Polpharma, Merck Sharp & Dohme, Pharmascience, Servier, Galenika, Pharmacosmos, Chiesi, as well as more than 50 other pharmaceutical manufacturers.

Medex is a marketing partner and the exclusive distributor for Bulgaria of:

Hamelin Pharma, Panpharma, Sanohemia Diagnostics.

Certificates

Medex is certified under ISO 9001:2015 and GDP by Lloyds Quality Assurance. The warehouse facility in Sofia covers approximately 8,000 square meters with a capacity of 4,200 Euro-pallets, while the warehouse in Varna covers 2,000 square meters with a capacity of 2,700 Euro-pallets. On average, more than half a million kilograms of goods leave the warehouses every month. The company operates 4 heavy-duty trucks, 8 medium-sized trucks, and over 20 smaller transport vehicles.